Correlation Between Novo Nordisk and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Genmab AS, you can compare the effects of market volatilities on Novo Nordisk and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Genmab AS.
Diversification Opportunities for Novo Nordisk and Genmab AS
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Novo and Genmab is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Genmab AS go up and down completely randomly.
Pair Corralation between Novo Nordisk and Genmab AS
Assuming the 90 days trading horizon Novo Nordisk AS is expected to generate 0.92 times more return on investment than Genmab AS. However, Novo Nordisk AS is 1.09 times less risky than Genmab AS. It trades about 0.1 of its potential returns per unit of risk. Genmab AS is currently generating about -0.02 per unit of risk. If you would invest 83,806 in Novo Nordisk AS on February 26, 2024 and sell it today you would earn a total of 9,074 from holding Novo Nordisk AS or generate 10.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Novo Nordisk AS vs. Genmab AS
Performance |
Timeline |
Novo Nordisk AS |
Genmab AS |
Novo Nordisk and Genmab AS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novo Nordisk and Genmab AS
The main advantage of trading using opposite Novo Nordisk and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.Novo Nordisk vs. Vestas Wind Systems | Novo Nordisk vs. Danske Bank AS | Novo Nordisk vs. Bavarian Nordic | Novo Nordisk vs. DSV Panalpina AS |
Genmab AS vs. Vestas Wind Systems | Genmab AS vs. Danske Bank AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. DSV Panalpina AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |